Analyst Reco. Virios Therapeutics, Inc.

Equities

Delayed Nasdaq Other stock markets 01:09:48 2024-04-29 pm EDT			5-day change	1st Jan Change
0.456 ^USD	-2.88%		+7.12%	-20.70%

Feb. 29	Virios Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
Jan. 22	Virios Therapeutics Announces Plans to Advance Development of Imc-2 as Treatment for Symptoms Associated with Long-Covid	CI

US Futures Lower as Investors Gird for Another Fed Rate Increase	22-09-20	MT
HC Wainwright Downgrades Virios Therapeutics to Neutral From Buy	22-09-20	MT
HC Wainwright Starts Virios Therapeutics at Buy With $12 Price Target	21-12-15	MT

No results for this search